Site updated at Wednesday, 22 June 2016

Living with Dementia


No Benefit for Dimebon in Huntington’s

An antihistamine that failed to work in Alzheimer’s disease also fell short of expectations in Huntington’s disease, researchers reported.

In a randomized controlled trial, latrepirdine (Dimebon) didn’t improve cognition or global function compared with placebo, Ray Dorsey, MD, of Johns Hopkins, and colleagues reported online in the Archives of Neurology.

Currently, medications can mitigate… No Benefit for Dimebon in Huntington’s   

Living With Dementia

cognitive1 - memory impairments1 - transdermal rivastigmine1 - alzheimer's changes2 - learning1 - intracoronary ultrasound1 - anticholinergics1 - miller fisher1 - parkinson's drug2 - cvd1 - a-beta protein1 - hyperlipidemia1 - synthetic tau fibrils1 - alzheimers society2 - journal of alzheimer's disease2 - preparing for appointment1 - difficulties with speech1 - mid-life factors1 - foolishness1 - irreversible dementia syndrome1 - poor judgment2 - university of pennsylvania2 - parkinson's disease dementia2 - psychometrics1 - ipscs1 - myelination1 - alpha-synuclein diseases1 - cholesterol1 - dementia of the alzheimer type1 - healthy diet1 -